Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19890183 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Rifaximin for Chronic Immune Activation in People With HIV
Condition: HIV
Intervention: Drug: Rifaximin/ Placebo

Study has passed its completion date and status has not been verified in more than two years.